Compare S&P500 ETF (SPY) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
S&P500 ETF vs 22nd Century Group Inc — how do they compare? S&P500 ETF trades at $778.47 (market cap $821.54B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: S&P500 ETF is far larger — about 1321505× 22nd Century Group Inc's market cap, and S&P500 ETF is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold S&P500 ETF for 205 Days and 22nd Century Group Inc for 32 Days on average.
| SPY | XXII | |
|---|---|---|
Market Cap | $821.54B | $621.67K |
Volume | 40,070,358 | 45,625 |
52-Week High | $779.14 | $483.00 |
52-Week Low | $631.99 | $0.80 |
Typical Hold Time | 205 Days | 32 Days |
Sector | — | Consumer Staples |
Enterprise Value | — | -$3.69M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SPY, the SPDR S&P 500 ETF, trades at $778.54, up 0.16% on the day, with a bullish technical signal driven by moving averages. The ETF is positioned near resistance at $777, with support at $771. Recent news highlights mixed sentiment, with some articles noting strong profit growth expectations for the S&P 500 in 2026 but potential headwinds from margin debt and slowing growth forecasts for 2027.
The outlook for SPY remains tied to broader market trends, with opportunities from potential year-end rallies and strong corporate earnings, but risks include macroeconomic volatility and elevated valuations. Investor sentiment is cautious amid warnings about market collapses and shifting profit growth projections.
22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.
While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About S&P500 ETF
The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on SPY →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
